Pfanstiehl Solutions for Complex Bispecific or Trispecific Antibody Formulations
Stabilising bispecific or trispecific monoclonal antibodies (mAbs) presents several challenges due to their complex structures and the increased likelihood of …
Stabilising bispecific or trispecific monoclonal antibodies (mAbs) presents several challenges due to their complex structures and the increased likelihood of …
Inhalation-grade excipients are specialised substances used in the formulation of inhalable pharmaceutical products. These excipients must meet stringent quality and …
Surfactants are critical components in pharmaceutical formulations, particularly in emulsions, suspensions and certain solid-dosage forms. They reduce surface tension between …
The development of high-concentration antibody formulations (HCAFs) of greater than 100mg/ml is essential for the creation of monoclonal antibody (mAb) …
High viscosity in protein therapeutics can have several harmful effects, both in terms of manufacturing and clinical administration. These include manufacturing …
Protein aggregation is the spontaneous clustering or clumping together of protein molecules, resulting in the formation of larger structures called …
Proteins in biologics and vaccine formulations are sensitive molecules that can undergo denaturation, aggregation or degradation under various conditions, such …
Antipeptide antibodies have a number of uses in biological research and bioassay; for example, they can be very useful for …
The interface between chemistry and biology becomes well and truly blurred by the cutting-edge technology of bioconjugation. The ability to chemically …
The interactions of carbohydrates with their receptors is one of the core principles that has allowed for the great diversity …
Welcome to part one of the Biosynth handbook of enzyme substrates. These important products find applications in various sectors from …
Dengue fever, caused by the dengue virus (DENV), is a human arboviral disease existing largely in tropical locations of the …
Like many other large global pharmaceutical companies, this industry leader was faced with the challenge of decentralised translation spend and …
A leading global pharmaceutical company asked RWS to deliver a machine translation (MT) solution that would deliver efficiency, scalability and …
This white paper outlines a structured approach for adopting, refining, and scaling GenAI technologies within the biopharmaceutical sector.